Kang Bei

This inventor holds 19 USPTO granted patents and 7 published patent applications, plus 12 CIPO patents and 10 EPO patents. Top assignees: Vibrant Holdings, LLC, Vibrant Holding, LLC. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kang Bei. Retrieved from https://idiyas.com/inventor/kang-bei

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 12 (Patent Applications = 9)

EPO Patents = 10 (Patent Applications = 18)

Average Co-Inventor Count = 5.4

ph-index = 5

Forward Citations = 71(Granted Patents)

Company Filing History:

18 out of 24

Vibrant Holdings, LLC

Years Active: 2015-2026

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12663418 - PEPTIDE MICROARRAYS AND NOVEL BIOMARKERS FOR CELIAC DISEASE (2026-06-23),

2. 12546781 - Methods and compositions for amplified electrochemiluminescence detection assays (2026-02-10),

3. 12454771 - Substrates, peptide arrays, and methods (2025-10-28),

4. 12319712 - Methods of synthesizing a polynucleotide array using photoactivated agents (2025-06-03),

5. 12251674 - Substrates, systems, and methods for array synthesis and biomolecular analysis (2025-03-18),

6. 11815512 - Methods, systems, and arrays for biomolecular analysis (2023-11-14),

7. 11674956 - Methods, systems, and arrays for biomolecular analysis (2023-06-13),

8. 11565231 - Substrates, peptide arrays, and methods (2023-01-31),

9. 11033904 - Methods, tools, and tool assemblies for biomolecular analysis using microarrays (2021-06-15),

10. 10900964 - Peptide microarrays and novel biomarkers for celiac disease (2021-01-26),

11. 10816553 - Methods and compositions for amplified electrochemiluminescence detection (2020-10-27),

12. 10799845 - Substrates, systems, and methods for array synthesis and biomolecular analysis (2020-10-13),

13. 10746732 - Methods, systems, and arrays for biomolecular analysis (2020-08-18),

14. 10486129 - Substrates, peptide arrays, and methods (2019-11-26),

15. 10286376 - Substrates, systems, and methods for array synthesis and biomolecular analysis (2019-05-14),

Title: The Innovative Contributions of Kang Bei

Introduction

Kang Bei is a prominent inventor based in San Mateo, California. He has made significant contributions to the field of biotechnology, particularly in the synthesis of polynucleotides and biomolecular analysis. With a total of 16 patents to his name, his work has advanced the understanding and application of DNA microarrays and related technologies.

Latest Patents

Kang Bei's latest patents include innovative methods for synthesizing a polynucleotide array using photoactivated agents. These methods describe the synthesis of DNA polynucleotides and their deprotection, as well as the use of these compounds in light-directed synthesis of DNA microarrays. Another notable patent involves substrates, systems, and methods for array synthesis and biomolecular analysis. This patent discloses formulations and substrates that include a porous layer for the synthesis and attachment of polymers or biomolecules. Additionally, it covers methods for high-efficiency coupling of biomolecules to a substrate.

Career Highlights

Kang Bei is currently associated with Vibrant Holdings, LLC, where he continues to push the boundaries of innovation in biotechnology. His work has not only contributed to scientific advancements but has also paved the way for practical applications in various fields.

Collaborations

Kang Bei has collaborated with notable colleagues, including John J Rajasekaran and Vasanth Jayaraman. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Kang Bei's contributions to the field of biotechnology through his patents and collaborations highlight his role as a leading inventor. His innovative methods and dedication to research continue to impact the scientific community positively.

Profile summary based on public USPTO records.